CCT2 and neoplasm: found that reduction in CCT2 inhibited tumor induction by Gli-1, and ubiquitination-mediated Gli-1 degradation by β-TrCP occurred during incomplete folding of Gli-1 in hypoxia. CCT2 correlates with Gli-1 expression is an important determinant of survival in the colorectal cancer patients.